336 related articles for article (PubMed ID: 11724649)
1. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?
Wong F; Siu S; Liu P; Blendis LM
Clin Sci (Lond); 2001 Dec; 101(6):621-8. PubMed ID: 11724649
[TBL] [Abstract][Full Text] [Related]
2. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
[TBL] [Abstract][Full Text] [Related]
3. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
[TBL] [Abstract][Full Text] [Related]
4. Cardiac hemodynamic profiles and pro-B-type natriuretic Peptide in cirrhotic patients undergoing liver transplantation.
Bernal V; Pascual I; Esquivias P; García-Gil A; Fernández C; Mateo JM; González M; Simón MA
Transplant Proc; 2009 Apr; 41(3):985-6. PubMed ID: 19376404
[TBL] [Abstract][Full Text] [Related]
5. Can pro-brain natriuretic peptide be used as a noninvasive predictor of elevated left ventricular diastolic pressures in patients with normal systolic function?
Joung B; Ha JW; Ko YG; Kang SM; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
Am Heart J; 2005 Dec; 150(6):1213-9. PubMed ID: 16338261
[TBL] [Abstract][Full Text] [Related]
6. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
Bredin F; Liska J; Franco-Cereceda A
Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
[TBL] [Abstract][Full Text] [Related]
7. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis.
Wong F; Liu P; Lilly L; Bomzon A; Blendis L
Clin Sci (Lond); 1999 Sep; 97(3):259-67. PubMed ID: 10464050
[TBL] [Abstract][Full Text] [Related]
8. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.
Tsutamoto T; Wada A; Maeda K; Hisanaga T; Mabuchi N; Hayashi M; Ohnishi M; Sawaki M; Fujii M; Horie H; Sugimoto Y; Kinoshita M
Eur Heart J; 1999 Dec; 20(24):1799-807. PubMed ID: 10581138
[TBL] [Abstract][Full Text] [Related]
9. In patients with severe systolic dysfunction, only brain natriuretic peptide is related to diastolic restrictive pattern.
Catuzzo B; Ciancamerla F; Bobbio M; Longo M; Trevi GP
J Card Fail; 2003 Aug; 9(4):303-10. PubMed ID: 13680551
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
Hoffmann U; Brueckmann M; Bertsch T; Wiessner M; Liebetrau C; Lang S; Haase KK; Borggrefe M; Huhle G
Clin Lab; 2005; 51(7-8):373-9. PubMed ID: 16122147
[TBL] [Abstract][Full Text] [Related]
12. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
13. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
[TBL] [Abstract][Full Text] [Related]
15. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
[TBL] [Abstract][Full Text] [Related]
16. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.
Arikan S; Tuzcu A; Gokalp D; Bahceci M; Danis R
Clin Endocrinol (Oxf); 2007 Aug; 67(2):202-7. PubMed ID: 17547691
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction.
Ikeda N; Yasu T; Nishikimi T; Nakamura T; Kubo N; Kawakami M; Momomura S; Saito M
Regul Pept; 2007 Jun; 141(1-3):154-8. PubMed ID: 17292492
[TBL] [Abstract][Full Text] [Related]
18. Changes in B-type natriuretic peptides after surgical ventricular restoration.
Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic potential of serum N-terminal pro-B-type brain natriuretic peptide level in detection of cardiac wall stress in women with polycystic ovary syndrome: a cross-sectional comparison study.
Celik O; Sahin I; Celik N; Hascalik S; Keskin L; Ozcan H; Uckan A; Kosar F
Hum Reprod; 2007 Nov; 22(11):2992-8. PubMed ID: 17855407
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.
Ogard CG; Engelmann MD; Kistorp C; Nielsen SL; Vestergaard H
Clin Endocrinol (Oxf); 2005 Nov; 63(5):493-8. PubMed ID: 16268799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
